You are here

Article metrics

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Sofosbuvir with ribavirin is safe and effective in hepatitis C genotype 1 with unfavourable pretreatment characteristics

 

Online download statistics by month:

Online download statistics by month: December 2013 to March 2024

AbstractFullPdf
Dec 201360512
Jan 201484814
Feb 20143226
Mar 20142633
Apr 20142916
May 20142341219
Jun 20141451829
Jul 201486169
Aug 20144445
Sep 20146657
Oct 20144247
Nov 20142523
Dec 20143033
Jan 20153404
Feb 20153464
Mar 20153011
Apr 2015703
May 20152613
Jun 20152703
Jul 20152541
Aug 20153713
Sep 20153112
Oct 20151900
Nov 20151725
Dec 20153602
Jan 20164511
Feb 20162410
Mar 2016712
Apr 20161305
May 20163300
Jun 2016901
Jul 20162443
Aug 20161901
Sep 20161821
Oct 20163413
Nov 20162610
Dec 20161201
Jan 20171011
Feb 20171720
Mar 20171355
Apr 20171824
May 20172223
Jun 20172600
Jul 20171700
Aug 20171600
Sep 20171600
Oct 20172731
Nov 20172810
Dec 20173100
Jan 20183411
Feb 20182600
Mar 20182610
Apr 20182710
May 20181400
Jun 20182700
Jul 20182810
Aug 20185800
Sep 20181422
Oct 20183810
Nov 20183200
Dec 20185000
Jan 20194000
Feb 20195710
Mar 20192400
Apr 20193900
May 20192900
Jun 20194300
Jul 20191510
Aug 20191454
Sep 20191000
Oct 20193700
Nov 20192621
Dec 20191700
Jan 20201310
Feb 20201800
Mar 20202401
Apr 20202200
May 20201400
Jun 20201300
Jul 20202211
Aug 20201011
Sep 20202400
Oct 20202800
Nov 20201400
Dec 2020800
Jan 20213400
Feb 20211200
Mar 20212400
Apr 2021600
May 2021800
Aug 2021100
Oct 20211601
Nov 20211410
Dec 20212300
Jan 20221910
Feb 20224600
Mar 20224400
Apr 20222110
May 20225510
Jun 20224000
Jul 20222910
Aug 20227901
Sep 20224630
Oct 20222710
Nov 20221801
Dec 20221400
Jan 20231620
Feb 20235600
Mar 2023910
Apr 2023400
May 20231000
Jun 2023400
Jul 20231000
Aug 20231600
Sep 20232000
Oct 20232500
Nov 20235310
Dec 20232410
Jan 2024901
Feb 20242411
Mar 20243910
Total3561161202